Novartis Patient Assistance Foundation: $2.8B Revenue, $2.9B Expenses

Novartis Patient Assistance Foundation pulls a D on the efficiency rubric. The composite of 42/100 reflects below-median performance on the bundle of factors — typically driven by thin operating reserves, volatile revenue, or outsized officer compensation relative to organizational size.

On revenue, Novartis Patient Assistance Foundation is among the largest U.S. nonprofits: $2.8B in 2023 reported revenue. Organizations at this scale typically operate hospitals, university systems, or national federations — the financial pattern looks more like a corporation than the small-charity stereotype. On the financial-health factor, Novartis Patient Assistance Foundation runs thin — assets relative to annual spending fall below the cushion nonprofit-finance experts typically recommend.

Five-year revenue trajectory is strongly positive: Novartis Patient Assistance Foundation has grown materially in real terms, which usually signals successful fundraising and program expansion. Current-officer compensation is not separately reported in the filing — typical for nonprofits where leadership is paid through a related entity (parent system, university, or foundation) rather than the filing organization itself, or for small organizations whose chief is a volunteer or board member. Novartis Patient Assistance Foundation is categorized under Health — the largest segment of U.S. nonprofit revenue, dominated by hospitals, hospital systems, and health-research organizations. The financial profile in this category is capital-intensive, with large balance sheets and program service revenue that often dwarfs donations.